An individualized innovative disease management is of great importance for people with
multiple sclerosis (pwMS) to cope with the complexity of this chronic, multidimensional …

For incurable diseases, such as multiple sclerosis (MS), the prevention of progression and
the preservation of quality of life play a crucial role over the entire therapy period. In MS …

Multiple sclerosis (MS), a demyelinating disease that causes focal white matter lesions, is
commonly associated with depression. However, it remains unclear whether depression risk …

Fatigue is one of the most disabling symptoms of Multiple Sclerosis (MS), affecting more
than 80% of patients over the disease course. Nevertheless, it has a multi-faceted and …

Background and Objectives Some patients with multiple sclerosis (MS) receiving
ocrelizumab (OCR) report worsening symptoms toward the end of the 6-month infusion cycle …

In multiple sclerosis (MS), the early detection of disease activity or progression is key to
inform treatment changes and could be supported by digital tools. We present a novel CE …

Multiple sclerosis (MS) is a frequent chronic inflammatory disease of the central nervous
system that affects patients over decades. As the monitoring and treatment of MS become …

Objective To examine the factor structure and sociodemographic correlates of a battery of
clinical neuropsychological tests administered in-home and via telephone. Method …

Introduction Physical fatigue can be a common reason for early retirement or sick leave
since it appears in the earliest stages of multiple sclerosis (MS). Therefore, a prompt and …

Background As disease-modifying therapies do not reverse the course of multiple sclerosis
(MS), assessment of therapeutic success involves documenting patient-reported outcomes …